Levin, Adeera;
Ahmed, Sofia B;
Carrero, Juan Jesus;
Foster, Bethany;
Francis, Anna;
Hall, Rasheeda K;
Herrington, Will G;
Hill, Guy;
Inker, Lesley A;
Kazancıoğlu, Rümeyza;
Lamb, Edmund;
Lin, Peter;
Madero, Magdalena;
McIntyre, Natasha;
Morrow, Kelly;
Roberts, Glenda;
Sabanayagam, Dharshana;
Schaeffner, Elke;
Shlipak, Michael;
Shroff, Rukshana;
Tangri, Navdeep;
Thanachayanont, Teerawat;
Ulasi, Ifeoma;
Wong, Germaine;
Yang, Chih-Wei;
Zhang, Luxia;
Robinson, Karen A;
Wilson, Lisa;
Wilson, Renee F;
Kasiske, Bertram L;
Cheung, Michael;
Earley, Amy;
Stevens, Paul E.
Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) updates the KDIGO 2012 guideline and has been developed with patient partners, clinicians, and researchers around the world, using robust methodology. This update, based on a su...
The scope of the guideline is urate-lowering therapy in patients with chronic kidney disease (not on dialysis) without symptomatic hyperuricemia (such as gout and/or uric acid stone formation). The guideline does not make recommendations about the management of uric-acid kidney stones or gout in people w...
The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. ...
Fabry disease (FD) is a genetic disease, with X-chromosome linked inheritance, due to variants in the GLA gene that encodes the α-galactosidase A (α-GAL) enzyme. The purpose of the present study was to create a consensus aiming to standardize the recommendations regarding the renal involvement of FD wi...
El presente trabajo se ha enfocado en documentar la variabilidad de la práctica
clínica, analizar sus causas y proponer estrategias orientadas a mejorarla; esto
fomenta la toma de decisiones efectivas y seguras, centradas en los pacientes,
por parte de los profesionales de la salud. Entre dichas estrat...
This guideline covers care and treatment for people with, or at risk of, chronic kidney disease
(CKD). It aims to prevent or delay the progression, and reduce the risk of complications and
cardiovascular disease. It also covers managing anaemia and hyperphosphataemia associated with
CKD.
NICE has produce...
La enfermedad renal crónica (ERC) es una enfermedad de etiología multifactorial caracterizada
por el deterioro progresivo de la tasa de filtración glomerular (TFG) en cinco estadios (1). Los
estadios 3b, 4 y 5 se caracterizan por una reducción de la TFG que va desde por debajo de 45
ml/min/1.73m2 has...
Cheung, Alfred;
Chag, Tara;
Cushman, William;
Furth, Susan;
Hou, Fan;
Ix, Joachim;
Knoll, Gregory;
Muntner, Paul;
Pecoits-Filho, Roberto;
Sarnak, Mark;
Tobe, Sheldon;
Tomson, Charles;
Lytvyn, Lyubov;
Craig, Jonathan;
Tunnicliffe, David;
Howell, Martin;
Tnoelli, Marcelo;
Cheung, Michael;
Earley, Amy;
Mann, Johannes.
The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease for patients not receiving dialysis represents an update to the KDIGO 2012 guideline on this topic. Development of this guideline update followed a rigorou...
The purpose of this guideline is to maximise the safety of adults with chronic kidney disease during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources....
